15 completed, 5 unknown, 3 recruiting, 2 terminated. 27 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 27 | Completed 15, Unknown 5, Recruiting 3, Terminated 2, Not yet recruiting 1, Withdrawn 1 |
Follow Functional Dyspepsia: new trials by email Literature Review of Functional Dyspepsia trials Research Report on Functional Dyspepsia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Evaluate the Efficacy and Safety of DA-9701 in Patients With Functional Dyspepsia DA-9701, DA-9701-R, DA-9701 Placebo - Functional Dyspepsia | Phase 4 | Recruiting | Dong-A ST Co., Ltd. | 300 | 2026-08-06 | 2026-08-10 |
| Efficacy of Clostridium Butyricum in Alleviating Anxiety and Depression in Patients With Functional Dyspepsia Clostridium butyricum, placebo - Functional Dyspepsia, Probiotics | Phase 4 | Recruiting | Xijing Hospital of Digestive Diseases | 180 | 2026-03-26 | 2026-10-13 |
| The Effects of STW 5-II on Duodenal Mucosa and Symptoms in Functional Dyspepsia STW 5-II, Placebo - Functional Dyspepsia | Phase 4 | Not yet recruiting | Universitaire Ziekenhuizen KU Leuven | 100 | 2025-09-30 | 2025-09-30 |
| Efficacy of Bacillus Coagulans in Alleviating Anxiety and Depression in Patients With Functional Dyspepsia Bacillus coagulans, placebo - Functional Dyspepsia, Probiotics | Phase 4 | Completed | Xijing Hospital of Digestive Diseases | 181 | 2025-09-18 | 2026-10-13 |
| Budesonide as a Treatment for Functional Dyspepsia budesonide, Mannitol - Functional Dyspepsia | Phase 4 | Recruiting | Universitaire Ziekenhuizen KU Leuven | 56 | 2024-05-01 | 2025-02-24 |
| Treatment Outcomes For Functional Dyspepsia Based On Current International Guidelines In Multi-Ethnic Asian Patients Treatment based on subtypes: Esomeprazole or Itopride, Treatment with proton pump inhibitor regardless of subtype: Esomeprazole - Functional Dyspepsia | Phase 4 | Unknown | University of Malaya | 180 | 2021-11-18 | 2023-05-16 |
| Neuro-immune Interactions and PPI Pantoprazole 40mg - Functional Dyspepsia | Phase 4 | Completed | Universitaire Ziekenhuizen KU Leuven | 60 | 2021-03-31 | 2025-01-28 |
| Efficacy of Linaclotide in Patients With Overlapping Functional Gastrointestinal Disorders Linaclotide, Lactulose, Omeprazol - Functional Dyspepsia, Constipation-predominant Irritable Bowel Syndrome | Phase 4 | Unknown | RenJi Hospital | 78 | 2021-01-01 | 2021-12-13 |
| Effect of STW5 (Iberogast ®) and STW5-II (Iberogast N®) on Transit and Tolerance of Intestinal Gas Iberogast® and Iberogast® N - Irritable Bowel Syndrome, Functional Dyspepsia | Phase 4 | Completed | Hospital Vall d'Hebron | 68 | 2020-09-03 | 2023-09-22 |
| International Clinical Study of Zhizhu Kuanzhong Capsule Zhizhu Kuanzhong Capsule, Zhizhu Kuanzhong Placebo Capsule - Functional Dyspepsia, Postprandial Distress Syndrome | Phase 4 | Unknown | Xiyuan Hospital of China Academy of Chinese Medical Sciences | 480 | 2019-10-24 | 2023-08-04 |
| Therapeutic Effect of Ursodeoxycholic Acid in Functional Dyspepsia Nutridrink, High resolution manometry probe, perfusion catheter - Functional Dyspepsia | Phase 4 | Unknown | Universitaire Ziekenhuizen KU Leuven | 16 | 2017-01-01 | 2024-07-10 |
| The Efficacy and Safety Study of Rikkunshito in Patients With Functional Dyspepsia Rikkunshito, Rikkunshito placebo - Functional Dyspepsia | Phase 4 | Completed | Osaka City University | 128 | 2014-04-03 | 2017-07-27 |
| The Efficacy and Safety of Qizhiweitong Granule on Patients With Functional Dyspepsia in a Multi-center Clinical Study Qizhiweitong granule - Functional Dyspepsia | Phase 4 | Completed | Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | 400 | 2013-12-01 | 2015-12-09 |
| Functional Dyspepsia: Validation of the Leuven Postprandial Distress Scale (LPDS) in a Placebo-controlled Trial itopride, Placebo - Functional Dyspepsia | Phase 4 | Completed | Universitaire Ziekenhuizen KU Leuven | 105 | 2013-09-01 | 2020-07-09 |
| Functional Dyspepsia: Validation of a Questionnaire for Symptom Assessment in FD PDS Subgroup Itopride, Placebo - Functional Dyspepsia, Postprandial Fullness Syndrome | Phase 4 | Completed | Universitaire Ziekenhuizen KU Leuven | 100 | 2013-02-22 | 2020-12-01 |
| A Study to Demonstrate the Efficacy and Safety of Motilitone® Motilitone ®, Pantoline®, Motilitone® and Pantoline® - Functional Dyspepsia | Phase 4 | Completed | Dong-A ST Co., Ltd. | 389 | 2012-08-01 | 2015-01-27 |
| Efficiency Study of Clarithromycin and Bismuth-containing Quadruple Therapy to Treat H.Pylori Esomeprazole, Amoxicillin, Clarithromycin - Functional Dyspepsia, Peptic Ulcer | Phase 4 | Completed | Shanghai Jiao Tong University School of Medicine | 180 | 2012-08-01 | 2013-06-04 |
| Empirical Rescue Therapies of Helicobacter Pylori Infection Proton Pump Inhibitor, Bismuth, Metronidazole - Functional Dyspepsia, Scarred Peptic Ulcer | Phase 4 | Completed | Shanghai Jiao Tong University School of Medicine | 424 | 2012-07-01 | 2013-06-04 |
| Bismuth Improves the Efficacy of Levofloxacin-containing Triple Therapy for Helicobacter Pylori Treatment Bismuth, Lansoprazole, Levofloxacin - Functional Dyspepsia, Peptic Ulcer | Phase 4 | Completed | Shanghai Jiao Tong University School of Medicine | 161 | 2012-05-01 | 2012-12-13 |
| The Clinical Significance of Acid Rebound in Functional Dyspepsia Placebo, Pantoprazole + Placebo - Functional Dyspepsia | Phase 4 | Terminated | Zealand University Hospital | 184 | 2011-05-01 | 2013-12-06 |
Showing 20 of 27. Sign in to see all of them.
Anxiety Disorders (2) · Depression (2) · Digestive System Diseases (2) · Irritable Bowel Syndrome (2) · Peptic Ulcer (2) · Constipation (1) · Disease (1) · Gastrointestinal Diseases (1) · Gastroparesis (1) · Inflammation (1) · Pathologic Processes (1) · Weight Loss (1)
Gastrointestinal Diseases (5) · Pathological Conditions, Signs and Symptoms (5) · Digestive System Diseases (4) · Intestinal Diseases (4) · Signs and Symptoms (3) · Stomach Diseases (3) · Behavior (2) · Behavioral Symptoms (2) · Colonic Diseases (2) · Colonic Diseases, Functional (2) · Duodenal Diseases (2) · Mental Disorders (2) · Body Weight (1) · Body Weight Changes (1) · Neurologic Manifestations (1)
Lansoprazole (4) · itopride (4) · Amoxicillin (3) · Bismuth (3) · Proton Pump Inhibitors (3) · Esomeprazole (2) · Pantoprazole (2) · Anti-Bacterial Agents (1) · Blood Specimen Collection (1) · Budesonide (1) · Clarithromycin (1) · DA-9701 (1) · Exercise (1) · Furazolidone (1) · Lactulose (1)
Universitaire Ziekenhuizen KU Leuven (7) · Shanghai Jiao Tong University School of Medicine (3) · Dong-A ST Co., Ltd. (2) · National Taiwan University Hospital (2) · Xijing Hospital of Digestive Diseases (2) · Chinese University of Hong Kong (1) · Hospital Vall d'Hebron (1) · Korea Health Industry Development Institute (1) · Korean College of Helicobacter and Upper Gastrointestinal Research (1) · Lotung Poh-Ai Hospital (1) · Osaka City University (1) · RenJi Hospital (1) · Union Hospital, Tongji Medical College, Huazhong University of Science and Technology (1) · University of Malaya (1) · Xiyuan Hospital of China Academy of Chinese Medical Sciences (1)
China (7) · Belgium (5) · South Korea (4) · Taiwan (3) · Australia (1) · Denmark (1) · Hong Kong (1) · Japan (1) · Malaysia (1) · Spain (1)
Jan Tack, M.D., Ph.D. (2) · Fang Lu, Md, Phd (1) · Geun Am Song, M.D., Ph.D. (1) · Hong Lu (1) · Hong Lu, M.D. (1) · Hoon Yong Jung, M.D., Ph.D. (1) · Hye Kyung Jung, M.D., Ph.D. (1) · Hyo Jin Park, M.D., Ph.D. (1) · Jan Tack, MD (1) · Jan Tack, MD, PhD (1) · Jin-sung Kim, Ph.D (1) · Jong Sun Ryu, M.D., Ph.D. (1) · Joon Sung Lee, M.D., Ph.D. (1)
PMID 20670451, PMID 20957498, PMID 23376004, PMID 26538208, PMID 29941708, PMID 35357058, PMID 35655286, PMID 39618195, PMID 40079184
2025 (1)